Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for prevention of contrast-induced nephropathy after coronary angiography
IRCT20190911044744N4Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of curcumin in contrast-induced nephropathy (CIN), sponsored by Shahid Sadoughi University of Medical Sciences. Started Dec 2023; status: completed.
02
Drugs
curcumin
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on IRCT20190911044744N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190911044744N4.